Ureteral Cancer
Showing 1 - 25 of >10,000
Combined Postoperative Radiotherapy With Kidney Sparing Surgery
Recruiting
- Locally Advanced
- Urothelial Carcinoma Ureter
- Radical surgery
- Kidney sparing surgery+Postoperative radiotheray
-
Beijing, China
- +1 more
Nov 2, 2023
Cancer, Urinary Obstruction, Malignancy Trial in Chicago (Ureteral Stent, Percutaneous Nephrostomy Tube Placement)
Not yet recruiting
- Cancer
- +5 more
- Ureteral Stent
- Percutaneous Nephrostomy Tube Placement
-
Chicago, IllinoisThe University of Chicago
Nov 28, 2022
Renal Cell Carcinoma, Adrenal Tumor, Nonfunctioning Kidney Trial (telesurgery by domestic surgical robot)
Not yet recruiting
- Renal Cell Carcinoma
- +13 more
- telesurgery by domestic surgical robot
- (no location specified)
Feb 12, 2023
Urinary Bladder Tumors, Tumor Metastasis, Ureteral Tumors Trial in New York, Myrtle Beach, Nashville (LOXO-435, Pembrolizumab)
Recruiting
- Urinary Bladder Neoplasms
- +2 more
-
New York, New York
- +2 more
Jan 31, 2023
Urological Malignancies, Prostate Cancer, Renal Cell Cancer Trial in Seoul
Recruiting
- Urological Malignancies
- +4 more
-
Seoul, Korea, Republic ofYonsei Severance Hospital
Jan 30, 2023
Renal Pelvic and Ureteral Tumors Trial in Guangzhou (rreversible electroporation (IRE), NanoKnife)
Completed
- Renal Pelvic and Ureteral Neoplasms
- rreversible electroporation (IRE)
- NanoKnife
-
Guangzhou, Guangdong, ChinaBiological treatment center in Fuda cancer hospital
Sep 1, 2021
Primary and Metastatic Tumors in Renal Cell Carcinoma and
Recruiting
- Renal Cell Carcinoma
- +4 more
- Immune checkpoint inhibitor targeting PD1
-
Philadelphia, PennsylvaniaFox Chase Cancer Center - Philadelphia
Jan 27, 2023
A Genotype-Phenotype Urothelial Cancer Registry
Recruiting
- Urothelial Cancer
- +3 more
- saliva sample and questionaire
- saliva sample, questionaire
-
Basking Ridge, New Jersey
- +3 more
Jun 2, 2022
Urothelial Cancer, Metastatic Urothelial Carcinoma, Metastatic Urothelial Carcinoma of the Renal Pelvis and Ureter Trial in
Recruiting
- Urothelial Cancer
- +3 more
- Sacituzumab Govitecan (SG)
- Enfortumab vedotin-ejfv (EV)
-
Boston, MassachusettsDana Farber Cancer Institute
Sep 28, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +13 more
- Pembrolizumab
- Propranolol Hydrochloride
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jun 8, 2022
Urothelial Carcinoma, Kidney Cancer, Ureter Cancer Trial in Toronto (drug, other, dietary supplement)
Completed
- Urothelial Carcinoma
- +3 more
- Denosumab
- +6 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Nov 22, 2021
Bladder Squamous Cell Carcinoma, Locally Advanced Bladder Carcinoma, Malignant Renal Pelvis Tumor Trial in Atlanta (procedure,
Not yet recruiting
- Bladder Squamous Cell Carcinoma
- +10 more
- Biospecimen Collection
- +5 more
-
Atlanta, Georgia
- +3 more
Feb 20, 2023
Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,
Active, not recruiting
- Hydronephrosis
- +18 more
- Durvalumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Urothelial Carcinoma, Bladder Cancer, Urethral Cancer Trial in United States (Biospecimen Collection)
Active, not recruiting
- Urothelial Carcinoma
- +3 more
- Biospecimen Collection
-
Los Angeles, California
- +7 more
Feb 14, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Not yet recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +31 more
- Diagnostic Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +18 more
- Enfortumab Vedotin
- Erdafitinib
-
Los Angeles, California
- +2 more
Jun 28, 2022
Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8, Stage 0a Ureter Cancer AJCC v8 Trial in
Active, not recruiting
- Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
- +17 more
- Gemcitabine Hydrochloride
-
Jacksonville, Florida
- +3 more
Jul 5, 2022
Blood and Tissue Samples From Locally Recurrent or Metastatic
Recruiting
- Localized Renal Pelvis and Ureter Urothelial Carcinoma
- +10 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 21, 2021
Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,
Recruiting
- Distal Urethral Cancer
- +8 more
- afatinib dimaleate
- laboratory biomarker analysis
-
Atlanta, Georgia
- +5 more
Sep 24, 2021
Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer Trial in Idaho Falls (diagnostic test, drug, other)
Recruiting
- Adenocarcinoma
- +75 more
- Biomarker Testing (L)
- +2 more
-
Idaho Falls, Idaho
- +1 more
Oct 18, 2022
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +41 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +23 more
- Atezolizumab
- +2 more
-
Riverside, California
- +8 more
Jul 16, 2022
Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),
Active, not recruiting
- Carcinoma, Transitional Cell
- +6 more
- enfortumab vedotin (EV)
- +4 more
-
Anchorage, Alaska
- +105 more
Dec 19, 2022
Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder
Active, not recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +35 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +7 more
Jan 3, 2023
Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral
Recruiting
- Locally Advanced Renal Pelvis Urothelial Carcinoma
- +20 more
- Atezolizumab
- +2 more
-
Duarte, California
- +16 more
Aug 10, 2022